A comprehensive view of respiratory/lung health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Direct Biologics launches Phase 3 clinical trial of injectable ExoFlo biopharmaceutical to treat moderate to severe acute respiratory distress syndrome caused by COVID-19; multicenter study to recruit 400 people, start on Aug. 1, complete in January 2023

AstraZeneca and Avillion’s PT027 albuterol, budesonide rescue inhaler shows significant reduction in risk of severe exacerbation in patients with moderate to severe asthma in Phase 3 trial; asthma affects 25 million in US, 339 worldwide

FDA approves Alembic Pharmaceuticals’ ANDA for arformoterol tartrate inhalation solution, 15 mcg/2 mL unit-dose to treat chronic obstructive pulmonary bronchoconstriction; drug is therapeutic equivalent of Sunovion Pharmaceuticals’ Brovana

FDA gives breakthrough therapy designation to Zambon’s inhaled colistimethate sodium powder to treat pulmonary exacerbations in non-cystic fibrosis bronchiectasis; treatment uses adaptive aerosol delivery battery-powered I-neb nebulizer

Low levels of vitamin K may impact some cognitive abilities in the elderly including orientation, calculation skills, language; vitamin K linked to bone, heart, kidney, lung, eye, nerve, cellular health: study

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count